Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD).
For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

Tonix Pharmaceuticals is also enrolling participants in a Phase 3 trial for fibromyalgia.
For more information, please visit www.thereliefstudy.com or www.clinicaltrials.gov (NCT04172831).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
11/04/19 8-K Current report filing
Related Documents
6
11/01/19 FWP Filing under Securities Act Rules 163/433 of free writing prospectuses 35
11/01/19 8-K Current report filing
Related Documents
38
11/01/19 8-K Current report filing
Related Documents
38
11/01/19 FWP Filing under Securities Act Rules 163/433 of free writing prospectuses 35
10/31/19 8-K Current report filing
Related Documents
7
10/25/19 UPLOAD SEC-generated letter
Related Documents
1
10/23/19 8-K Current report filing
Related Documents
5
10/18/19 S-1 General form of registration statement for all companies including face-amount certificate companies
Related Documents
75
10/16/19 8-K Current report filing
Related Documents
170